Aduro BioTech Secures $6,500,000 New Financing

  • Feed Type
  • Date
    1/31/2013
  • Company Name
    Aduro BioTech
  • Mailing Address
    626 Bancroft Way Berkeley, CA 94710
  • Company Description
    Aduro BioTech is a clinical-stage immunotherapy company with a platform technology for therapeutic and prophylactic vaccines for cancer and infectious diseases. The platform of attenuated and targeted vaccines based on Listeria monocytogenes has been in development for nine years.
  • Website
    http://www.adurobiotech.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $6,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    This financing will help fund further execution and expansion of Aduro’s targeted immunotherapy development efforts.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.